REAL WORLD EVIDENCE

JCDC has established a Centre for Excellence (CoE) for Real World Evidence (RWE) Generation. We focus on collecting and analyzing real world data (RWD) generated from clinical practice or available from other sources, to support evidence-based clinical, economic and regulatory decisions. Strong clinical, medical, analytical and global delivery strengths alongwith expertise in clinical operations, site management, data management, hospital relationships and technology partnerships make JCDC the right partner for RWE studies.

Our real-world evidence is generated through the study of data captured in a real-world clinical practice environment, namely outside a conventional clinical trial setting. We transform the real-world data into evidence which can be used to generate insights and drive understanding for our clients.

At Jehangir Hospital, we have access to almost 1 million+ Health Information System (HIS) records. Moreover, with our relations with over 300+ partner hospitals in India we have access to millions of Health Records for retrospective and prospective studies

Services provided

RWE Strategy

Integrate stakeholder requirements and define an RWE strategy

Clinical development programs
Target product profile
Commercialization plans across geographies
Comparative effectiveness

Observational Studies

Conduct and execution of observational studies viz.

Retrospective and prospective
Patient registries, chart reviews, surveys, disease background reviews
Burden of illness studies
Studies to help devise strategies to improve adherence, and establish safety profile

Technology Support

Digitization solutions for real world data
Healthcare data warehousing and analytics platform
Patient support services solutions

User Friendly &
Agile EDC

Case Studies – RWE,
Observational, Epi studies

Immunogenicity & HPV infection

Covid RWE
Project

Breast Cancer
Epidemiology project

US Retrospective
Chart Review Project

Central Ethics
Committee

Selected in 2009 for a prestigious WHO study

Recruited 3000+
(15%) participants
out of a total samples size of 20,000 participants in India.

The paper is published in Lancet Oncology

Completed RWE project from Data entry to data QC, cleaning and DB lock for 1,000 Covid 19 patients.

This project was done across 8 hospitals in Pune.

End to End project was completed
in 4 months

Epidemiology study
in Breast Cancer in collaboration with TATA Memorial.

Sample size of approx 1,000 + breast cancer patients where demographic, social, lifestyle and clinical details were captured

Published in ASCO

Collection of Brief Agitation Rating Scale (BARS) data or ER /Psychiatry notes

Patients with documented history of SMI (SCZ or bipolar illness) for at least 2 years

Data collected from 4 Hospitals in the US

Central Ethics Committee for
the largest ever observational study conducted pan India involving 389 sites.

Long term Registry on Type 2 diabetes mellitus patients to observe results of different treatments on health effects